CA Patent

CA2396579A1 — Tricyclic protein kinase inhibitors

Assigned to Wyeth LLC · Expires 2001-07-05 · 25y expired

What this patent protects

This invention provides compounds of formula (1) which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.

USPTO Abstract

This invention provides compounds of formula (1) which are useful as inhibitors of protein tyrosine kinase and are antiproliferative agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2396579A1
Jurisdiction
CA
Classification
—
Expires
2001-07-05
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.